Global Information
회사소개 | 문의 | 위시리스트

심장 마커 신속검사 및 POC(Point of Care) 검사 : 의료기기 파이프라인 평가

Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019

리서치사 GlobalData
발행일 2019년 12월 상품 코드 667070
페이지 정보 영문 130 Pages
가격
US $ 4,000 ₩ 4,735,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,000 ₩ 9,470,000 PDF by E-mail (Site License) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 12,000 ₩ 14,205,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


심장 마커 신속검사 및 POC(Point of Care) 검사 : 의료기기 파이프라인 평가 Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019
발행일 : 2019년 12월 페이지 정보 : 영문 130 Pages

심장 마커 신속검사 및 POC(Point of Care) 검사 파이프라인 제품에 대해 조사 분석했으며, 개발 단계별 비교 분석, 주요 기업, 진행중인 임상시험 등의 정보를 정리하여 전해드립니다.

제1장 목차

제2장 서론

  • 심장 마커 신속검사 및 POC 검사 개요

제3장 개발중인 제품

  • 심장 마커 신속검사 및 POC 검사 - 파이프라인 제품 : 개발 단계별
  • 심장 마커 신속검사 및 POC 검사 - 파이프라인 제품 : 부문별
  • 심장 마커 신속검사 및 POC 검사 - 파이프라인 제품 : 지역별
  • 심장 마커 신속검사 및 POC 검사 - 파이프라인 제품 : 규제 경로별
  • 심장 마커 신속검사 및 POC 검사 - 파이프라인 제품 : 승인 예정일별

제4장 심장 마커 신속검사 및 POC 검사 - 개발중인 파이프라인 제품 : 기업별

  • 심장 마커 신속검사 및 POC 검사 기업 - 파이프라인 제품 : 개발 단계별
  • 심장 마커 신속검사 및 POC 검사 - 파이프라인 제품 : 개발 단계별

제5장 심장 마커 신속검사 및 POC 검사 기업과 제품 개요

  • 1Drop Diagnostics
  • Abionic SA
  • Accel Diagnostics LLC
  • Akers Biosciences Inc
  • Akrivis Technologies LLC
  • Alfa Wassermann Inc
  • Anteo Diagnostics Ltd
  • Atonomics A/S
  • Axela Inc
  • Axis-Shield Diagnostics Ltd
  • BBB Technologies Inc
  • Bio-Alternative Medical Devices Ltd
  • BioMedomics Inc
  • BiOracle Ltd(휴지중)
  • Biosensia Ltd
  • Biostealth, Inc.
  • Biosurfit, SA
  • Carclo Diagnostic Solutions Ltd
  • CardioGenics Inc
  • Cordex Systems, LLC
  • Critical Diagnostics
  • Diazyme Laboratories Inc
  • Duke University
  • Dynasil Corporation of America
  • Edan Instruments Inc
  • Epinex Diagnostics Inc
  • ET Healthcare, Inc.
  • General Biologicals Corp
  • Group K Diagnostics
  • LeukoDx Ltd
  • MML Ltd
  • Nanomix Inc
  • Novartis AG
  • Ohmx Corp
  • OPKO Health Inc
  • Prolight Diagnostics AB
  • QLIDA Diagnostics
  • QuickCheck Health In
  • Radiometer Medical ApS
  • Radisens Diagnostics Ltd
  • Resdin Technologies Inc.
  • Sandia National Laboratories
  • Sarissa-Biomedical Ltd
  • Selfa, Inc.
  • SpinChip Diagnostics AS
  • Thermo Fisher Scientific Inc
  • ThreeFold Sensors(휴지중)
  • Trinity Biotech Plc
  • True Diagnostics Inc
  • Universal Biosensors Inc
  • Upstream Medical Technologies Ltd
  • XCellCure, LLC

제6장 심장 마커 신속검사 및 POC 검사 : 최근 동향

제7장 부록

LSH 18.08.14

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

List of Tables

  • Table 1: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 13
  • Table 2: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Segment 14
  • Table 3: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Territory 15
  • Table 4: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path 16
  • Table 5: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date 17
  • Table 6: Cardiac Markers Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development 18
  • Table 7: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 21
  • Table 8: 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 9: One Drop Diagnostic Device - Cardiovascular Disease - Product Status 24
  • Table 10: One Drop Diagnostic Device - Cardiovascular Disease - Product Description 24
  • Table 11: Abbott Point of Care Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 12: i-STAT TnI-Nx - Product Status 25
  • Table 13: i-STAT TnI-Nx - Product Description 25
  • Table 14: Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 15: pScreen BNP - Product Status 26
  • Table 16: pScreen BNP - Product Description 26
  • Table 17: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 18: Diagnostic Test - Heart Attack - Product Status 28
  • Table 19: Diagnostic Test - Heart Attack - Product Description 28
  • Table 20: Akrivis Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 21: Z-TECT - cTnI Assay - Product Status 30
  • Table 22: Z-TECT - cTnI Assay - Product Description 30
  • Table 23: Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 24: ACE Alera Clinical Chemistry System - hsCRP Assay - Product Status 31
  • Table 25: ACE Alera Clinical Chemistry System - hsCRP Assay - Product Description 31
  • Table 26: ACE Axcel Clinical Chemistry System - hsCRP Assay - Product Status 32
  • Table 27: ACE Axcel Clinical Chemistry System - hsCRP Assay - Product Description 32
  • Table 28: Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 29: Cardiac Troponin Biomarker Kit - Product Status 33
  • Table 30: Cardiac Troponin Biomarker Kit - Product Description 33
  • Table 31: Anteo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 32: AtomoRapid - Heart Attack - Product Status 34
  • Table 33: AtomoRapid - Heart Attack - Product Description 34
  • Table 34: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 35: Premium Trace - B-type Natriuretic Peptide Assay - Product Status 36
  • Table 36: Premium Trace - B-type Natriuretic Peptide Assay - Product Description 36
  • Table 37: Trace - D-dimer Test - Product Status 37
  • Table 38: Trace - D-dimer Test - Product Description 37
  • Table 39: Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 40: Afinion hsCRP Assay - Product Status 38
  • Table 41: Afinion hsCRP Assay - Product Description 38
  • Table 42: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 43: Mobile RDT Reader - Troponin-I Test - Product Status 39
  • Table 44: Mobile RDT Reader - Troponin-I Test - Product Description 39
  • Table 45: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 46: Digital Strip Reader - Cardiac Marker Test - Product Status 41
  • Table 47: Digital Strip Reader - Cardiac Marker Test - Product Description 41
  • Table 48: Magnetic Immunoassay Detection System - Cardiac Myoglobin - Product Status 42
  • Table 49: Magnetic Immunoassay Detection System - Cardiac Myoglobin - Product Description 42
  • Table 50: Magnetic Immunoassay Detection System - Cardiac Troponin - Product Status 42
  • Table 51: Magnetic Immunoassay Detection System - Cardiac Troponin - Product Description 44
  • Table 52: Magnetic Immunoassay Detection System - CK MB - Product Status 44
  • Table 53: Magnetic Immunoassay Detection System - CK MB - Product Description 44
  • Table 54: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 55: Point of Care Test - Troponin - Product Status 45
  • Table 56: Point of Care Test - Troponin - Product Description 45
  • Table 57: BiOracle Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 58: biO1042 Test - Product Status 46
  • Table 59: biO1042 Test - Product Description 46
  • Table 60: Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

List of Figures

  • Figure 1: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 11
  • Figure 2: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Segment 12
  • Figure 3: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Territory 13
  • Figure 4: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path 14
  • Figure 5: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date 15

GlobalData's Medical Devices sector report, "Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019" provides an overview of Cardiac Markers Rapid Tests & Point of Care (POC) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Markers Rapid Tests & Point of Care (POC) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Markers Rapid Tests & Point of Care (POC) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Markers Rapid Tests & Point of Care (POC) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Markers Rapid Tests & Point of Care (POC) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables 5
  • 1.2 List of Figures 9

2 Introduction 10

  • 2.1 Cardiac Markers Rapid Tests & Point of Care (POC) Overview 10

3 Products under Development 11

  • 3.1 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 11
  • 3.2 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Segment 12
  • 3.3 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Territory 13
  • 3.4 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path 14
  • 3.5 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date 15

4 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products under Development by Companies 16

  • 4.1 Cardiac Markers Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development 16
  • 4.2 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development 19

5 Cardiac Markers Rapid Tests & Point of Care (POC) Companies and Product Overview 22

  • 5.1 1Drop Diagnostics Company Overview 22
    • 5.1.1 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.2 Abbott Point of Care Inc Company Overview 23
    • 5.2.1 Abbott Point of Care Inc Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.3 Accel Diagnostics LLC Company Overview 24
    • 5.3.1 Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.4 Akers Biosciences Inc Company Overview 25
    • 5.4.1 Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.5 Akrivis Technologies LLC Company Overview 26
    • 5.5.1 Akrivis Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.6 Alfa Wassermann Inc Company Overview 27
    • 5.6.1 Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.7 Angle Biosciences Inc Company Overview 29
    • 5.7.1 Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.8 Anteo Diagnostics Ltd Company Overview 30
    • 5.8.1 Anteo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.9 Atonomics A/S Company Overview 31
    • 5.9.1 Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.10 Axis-Shield Diagnostics Ltd Company Overview 33
    • 5.10.1 Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.11 BBB Technologies Inc Company Overview 34
    • 5.11.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.12 Bio-AMD Inc Company Overview 35
    • 5.12.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.13 BioMedomics Inc Company Overview 38
    • 5.13.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.14 BiOracle Ltd (Inactive) Company Overview 39
    • 5.14.1 BiOracle Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.15 Biosensia Ltd Company Overview 40
    • 5.15.1 Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.16 Biostealth, Inc. Company Overview 41
    • 5.16.1 Biostealth, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.17 Biosurfit, SA Company Overview 42
    • 5.17.1 Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.18 Brava Diagnostics Company Overview 43
    • 5.18.1 Brava Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.19 Carclo Diagnostic Solutions Ltd Company Overview 44
    • 5.19.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.20 CardioGenics Inc Company Overview 45
    • 5.20.1 CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.21 Cordex Systems, LLC Company Overview 46
    • 5.21.1 Cordex Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.22 Coris BioConcept Company Overview 47
    • 5.22.1 Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.23 Critical Diagnostics Company Overview 48
    • 5.23.1 Critical Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.24 Diazyme Laboratories Inc Company Overview 49
    • 5.24.1 Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.25 DSC Technologies Inc Company Overview 50
    • 5.25.1 DSC Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.26 Duke University Company Overview 51
    • 5.26.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.27 Dynasil Corporation of America Company Overview 53
    • 5.27.1 Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview 53
  • 5.28 Edan Instruments Inc Company Overview 54
    • 5.28.1 Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.29 Epinex Diagnostics Inc Company Overview 57
    • 5.29.1 Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.30 ET Healthcare Inc Company Overview 58
    • 5.30.1 ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.31 Group K Diagnostics Company Overview 61
    • 5.31.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.32 LeukoDx Ltd Company Overview 63
    • 5.32.1 LeukoDx Ltd Pipeline Products & Ongoing Clinical Trials Overview 63
  • 5.33 MML Ltd Company Overview 64
    • 5.33.1 MML Ltd Pipeline Products & Ongoing Clinical Trials Overview 64
  • 5.34 Nanomix Inc Company Overview 66
    • 5.34.1 Nanomix Inc Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.35 Novartis AG Company Overview 68
    • 5.35.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.36 Ohmx Corp Company Overview 69
    • 5.36.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.37 OPKO Health Inc Company Overview 73
    • 5.37.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.38 Prolight Diagnostics AB Company Overview 75
    • 5.38.1 Prolight Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 75
  • 5.39 QLIDA Diagnostics Company Overview 76
    • 5.39.1 QLIDA Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.40 QuickCheck Health Inc Company Overview 77
    • 5.40.1 QuickCheck Health Inc Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.41 Quidel Corp Company Overview 78
    • 5.41.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 78
  • 5.42 Radiometer Medical ApS Company Overview 79
    • 5.42.1 Radiometer Medical ApS Pipeline Products & Ongoing Clinical Trials Overview 79
  • 5.43 Radisens Diagnostics Ltd Company Overview 80
    • 5.43.1 Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 80
  • 5.44 Resdin Technologies Inc. Company Overview 81
    • 5.44.1 Resdin Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
  • 5.45 Sandia National Laboratories Company Overview 82
    • 5.45.1 Sandia National Laboratories Pipeline Products & Ongoing Clinical Trials Overview 82
  • 5.46 Sarissa-Biomedical Ltd Company Overview 85
    • 5.46.1 Sarissa-Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview 85
  • 5.47 Selfa, Inc. Company Overview 86
    • 5.47.1 Selfa, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86
  • 5.48 SpinChip Diagnostics AS Company Overview 87
    • 5.48.1 SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 87
  • 5.49 Thermo Fisher Scientific Inc Company Overview 88
    • 5.49.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 88
  • 5.50 ThreeFold Sensors (Inactive) Company Overview 89
    • 5.50.1 ThreeFold Sensors (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 89
  • 5.51 Trinity Biotech Plc Company Overview 90
    • 5.51.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 90
  • 5.52 True Diagnostics Inc Company Overview 93
    • 5.52.1 True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 93
  • 5.53 Universal Biosensors Inc Company Overview 94
    • 5.53.1 Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview 94
  • 5.54 University of Vermont Company Overview 95
    • 5.54.1 University of Vermont Pipeline Products & Ongoing Clinical Trials Overview 95
  • 5.55 Upstream Medical Technologies Ltd Company Overview 96
    • 5.55.1 Upstream Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 96
  • 5.56 XCellCure, LLC Company Overview 105
    • 5.56.1 XCellCure, LLC Pipeline Products & Ongoing Clinical Trials Overview 105

6 Cardiac Markers Rapid Tests & Point of Care (POC) - Recent Developments 108

  • 6.1 Oct 23, 2019: bioMerieux - Third-Quarter 2019 Business Review 108
  • 6.2 Oct 22, 2019: bioMerieux - Third quarter 2019 business review 109
  • 6.3 Oct 16, 2019: Trinity Biotech announces results for Q3, 2019 111
  • 6.4 Sep 04, 2019: bioMerieux announces First-Half 2019 Results 112
  • 6.5 Aug 20, 2019: Trinity Biotech announces results for Q2, 2019 115
  • 6.6 May 07, 2019: Trinity Biotech announces results for Q1, 2019 117
  • 6.7 Apr 24, 2019: bioMerieux: First-quarter 2019 business review 119
  • 6.8 Mar 07, 2019: Trinity Biotech announces quarter 4 and fiscal year 2018 financial results 120
  • 6.9 Feb 27, 2019: bioMerieux - 2018 Financial Results 122
  • 6.10 Jan 25, 2019: Introducing DiaSys' new CEO Dr. Jan Gorka 126
  • 6.11 Dec 07, 2018: Quidel comments on California court ruling 126

7 Appendix 127

  • 7.1 Methodology 127
  • 7.2 About GlobalData 130
  • 7.3 Contact Us 130
  • 7.4 Disclaimer 130
Back to Top
전화 문의
F A Q